Matching Presbyopia-Correcting Technology to the Individual -

Name: Matching Presbyopia-Correcting Technology to the Individual Cataract Patient's Needs
Uploaded: 2021-09-07T04:00:00+00:00
Description: Drs. Constance Okeke and Brandon Ayres describe their current treatment strategies for patients seeking spectacle independence and vision at all distances.

Overview
Drs. Constance Okeke and Brandon Ayres describe their current treatment strategies for patients seeking spectacle independence and vision at all distances. They discuss how to manage patient expectations for presbyopia correcting IOL patients during the preoperative consultation, and how to determine the visual distance needs of presbyopia patients. They describe how they manage patients with comorbid conditions, like glaucoma, post-corneal refractive surgery, and other corneal abnormalities.
This activity is supported by an unrestricted educational grant from Alcon Vision, Johnson & Johnson Vision, and Orasis Pharmaceuticals
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Describe how new presbyopia-correcting IOL designs help to maximize vision at all distances and maximize visual quality and mitigate dysphotopsia
- Identify necessary steps to achieve emmetropia in presbyopia-correcting IOL patients
Accreditation
Jointly Proviced by Evolve Medical Education and The Fundingsland Group
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education LLC (Evolve) and The Fundingsland Group. Evolve is accredited by the ACCME to provide continuing medical education for physicians.
DESIGNATION STATEMENT
Evolve designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participation Method
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Faculty and Disclosures
Brandon D. Ayres, MD
Cornea Service
Wills Eye Hospital
Philadelphia, PA

Constance Okeke, MD, MSCE
Glaucoma & Cataract Specialist
CVP Physicians/Virginia Eye Consultants
Assistant Professor of Ophthalmology
Eastern Virginia Medical School
Norfolk, Virginia

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Brandon D. Ayres, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon Vision, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Dompé, Eyevance, Eyepoint Pharmaceuticals, Glaukos, Gore Surgical, Kala, Omeros, Microsurgical Technology, Mojo, Novartis, Sight Sciences, and TearLab. Speaker’s Bureau: Alcon Vision, Allergan, and Dompé.
Constance Okeke, MD, MSCE,has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie Pharmaceuticals, Akorn, Alcon Vision, Allergan, Bausch + Lomb, Nova Eye Medical, Eyenovia, Glaukos, Ivantis, MST, Sight Sciences, Sun Pharmaceutical Industries, and Thea. Grant/ResearchSupport: Bausch + Lomb, Glaukos, and Nicox. Speaker’s Bureau: Aerie Pharmaceuticals, Allergan, Bausch + Lomb, MST, and Sun Pharmaceutical Industries. Stock/Shareholder: Mediprint, and Visionology. Other Financial Support: Kugler Publications.
The Evolve and The Fundingsland Group staff and planners have no financial relationships with commercial interests. Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group, Alcon Vision, Johnson & Johnson Vision, and Orasis Pharmaceuticals.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date: 09/07/2021
Expiration Date: 09/30/2022

Constance Okeke, MD, MSCE

Guest

Brandon D. Ayres, MD

Guest

Matching Presbyopia-Correcting Technology to the Individual Cataract Patient's Needs

Title

Share on ReachMD